Ngā hua rapu - Chang‐Fang Chiu

  • E whakaatu ana i te 1 - 19 hua o te 19
Whakamahine hua
  1. 1
    Significant Difference in the Trends of Female Breast Cancer Incidence Between Taiwanese and Caucasian Americans: Implications from Age-Period-Cohort Analysis

    Significant Difference in the Trends of Female Breast Cancer Incidence Between Taiwanese and Caucasian Americans: Implications from Age-Period-Cohort Analysis mā Ying‐Chun Shen, Chee‐Jen Chang, Chiun Hsu, Chia-Chi Cheng, Chang-Fang Chiu, Ann‐Lii Cheng

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Cucurbitane Triterpenoid from<i>Momordica charantia</i>Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor<i>γ</i>Activation

    Cucurbitane Triterpenoid from<i>Momordica charantia</i>Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor<i>γ</i>Ac... mā Jing‐Ru Weng, Li-Yuan Bai, Chang-Fang Chiu, Jing-Lan Hu, Shih-Jiuan Chiu, Chia-Yung Wu

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Virus Infection in Patients With Histiocytic Necrotizing Lymphadenitis in Taiwan

    Virus Infection in Patients With Histiocytic Necrotizing Lymphadenitis in Taiwan mā Chang-Fang Chiu, Kuan‐Chih Chow, Tze‐Yi Lin, Ming‐Hsui Tsai, Chi-Min Shih, Li-Mien Chen

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    A triterpenoid from wild bitter gourd inhibits breast cancer cells

    A triterpenoid from wild bitter gourd inhibits breast cancer cells mā Li-Yuan Bai, Chang-Fang Chiu, Po‐Chen Chu, Wei-Yu Lin, Shih-Jiuan Chiu, Jing‐Ru Weng

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer

    Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer mā Chia-Ing Jan, Ming-Hsui Tsai, Chang-Fang Chiu, Yi‐Ping Huang, Chia Jen Liu, Nai Wen Chang

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Short-term effect of internet-delivered mindfulness-based stress reduction on mental health, self-efficacy, and body image among women with breast cancer during the COVID-19 pandemic

    Short-term effect of internet-delivered mindfulness-based stress reduction on mental health, self-efficacy, and body image among women with breast cancer during the COVID-19 pandem... mā Yun‐Chen Chang, Chang‐Fang Chiu, Chih-Kai Wang, Chen-Teng Wu, Liang‐Chih Liu, Yao‐Chung Wu

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    AMPK‐dependent signaling modulates the suppression of invasion and migration by fenofibrate in <scp>CAL</scp> 27 oral cancer cells through <scp>NF</scp>‐κ<scp>B</scp> pathway

    AMPK‐dependent signaling modulates the suppression of invasion and migration by fenofibrate in <scp>CAL</scp> 27 oral cancer cells through <scp>NF</scp>‐κ<scp>B</scp> pathway mā Shih‐Chang Tsai, Ming‐Hsui Tsai, Chang‐Fang Chiu, Chi‐Cheng Lu, Sheng‐Chu Kuo, Nai‐Wen Chang, Jai‐Sing Yang

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: No impact on early mortality and intracranial hemorrhage

    Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: No impact on early mortality and intracranial hemorrhage mā Ming‐Chih Chang, Tsai‐Yun Chen, Jih‐Luh Tang, Yii‐Jenq Lan, Tsu‐Yi Chao, Chang‐Fang Chiu, Hsin‐Tsung Ho

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study

    Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study mā Ming-Yu Lien, Chia-Hui Chou, Ching‐Chan Lin, Li‐Yuan Bai, Chang‐Fang Chiu, Su‐Peng Yeh, Mao-Wang Ho

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Associations between accurate prognostic understanding and end‐of‐life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012

    Associations between accurate prognostic understanding and end‐of‐life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012... mā Siew Tzuh Tang, Tsang‐Wu Liu, Jyh‐Ming Chow, Chang‐Fang Chiu, Ruey‐Kuen Hsieh, Chen H. Chen, Li Ni Liu, Wei‐Lien Feng

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents–A drug repurposing strategy

    Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents–A drug repurposing strategy mā Chia-Hsien Wu, Li-Yuan Bai, Ming-Hsui Tsai, Po‐Chen Chu, Chang-Fang Chiu, Michael Yuan‐Chien Chen, Shih-Jiuan Chiu, Jo‐Hua Chiang, Jing‐Ru Weng

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) ± 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy

    CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) ± 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocar... mā Li‐Tzong Chen, Andrea Wang‐Gillam, Yan‐Shen Shan, Teresa Macarulla, Jean-Frédéric Blanc, Richard Hubner, Chang-Fang Chiu, Gilberto Schwartsmann, Jens T. Siveke, Pipas J. Marc, Bruce Belanger, F. de Jong, Khalid Mamlouk, Daniel D. Von Hoff

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study

    Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study mā Yung‐Jue Bang, Chung–Pin Li, Kyung‐Hun Lee, Chang‐Fang Chiu, Joon Oh Park, Yan‐Shen Shan, Jun Suk Kim, Jen‐Shi Chen, Hyun‐Jeong Shim, Kun‐Ming Rau, Hye Jin Choi, Do‐Youn Oh, Bruce Belanger, Li‐Tzong Chen

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study

    Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study mā Chiun Hsu, Hsiao‐Hui Tsou, Shyh-Jer Lin, Ming-Chung Wang, Ming Yao, Wen-Li Hwang, Woei-Yau Kao, Chang-Fang Chiu, Sheng-Fung Lin, Johnson Lin, Cheng-Shyong Chang, Hwei‐Fang Tien, Tsang-Wu Liu, Pei‐Jer Chen, Ann‐Lii Cheng

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial

    Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: E... mā Li‐Tzong Chen, Jens T. Siveke, Andrea Wang‐Gillam, Chung–Pin Li, G. Bodoky, Andrew Dean, Yan‐Shen Shan, Gayle Jameson, Teresa Macarulla, Kyung-Hun Lee, David Cunningham, Jean-Frédéric Blanc, Chang-Fang Chiu, Gilberto Schwartsmann, Fadi S. Braiteh, Khalid Mamlouk, Bruce Belanger, Floris A. de Jong, Richard Hubner

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy

    Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocar... mā Jean-Frédéric Blanc, Richard Hubner, Chung‐Pin Li, Andrea Wang‐Gillam, G. Bodoky, Andrew Dean, Yan‐Shen Shan, Gayle Jameson, Teresa Macarulla, Kyung-Hun Lee, David Cunningham, Chang-Fang Chiu, Gilberto Schwartsmann, Fadi Braiteh, Daniel D. Von Hoff, Li‐Tzong Chen, Khalid Mamlouk, Parul Bhargava, F. de Jong, Jens T. Siveke

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    A targeted next‐generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice

    A targeted next‐generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice mā Po‐Han Lin, Huei‐Ying Li, Sheng‐Chih Fan, Tzu‐Hang Yuan, Ming Chen, Yu‐Hua Hsu, Yu‐Hsuan Yang, Long‐Yuan Li, Su‐Peng Yeh, Li‐Yuan Bai, Yu‐Min Liao, Chen‐Yuan Lin, Ching‐Yun Hsieh, Ching‐Chan Lin, Che‐Hung Lin, Ming‐Yu Lien, Tzu‐Ting Chen, Yen‐Hsuan Ni, Chang‐Fang Chiu

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

    Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial mā Thomas Yau, Peter R. Galle, Thomas Decaens, Bruno Sangro, Shukui Qin, Leonardo Gomes da Fonseca, Hatim Karachiwala, Jean‐Frédéric Blanc, Joong‐Won Park, Edward Gane, Matthias Pinter, Ana Matilla Peña, Masafumi Ikeda, David Tai, Armando Santoro, Gonzalo Pizarro, Chang‐Fang Chiu, Michael Schenker, Aiwu Ruth He, Hong Jae Chon, Joanna Wójcik-Tomaszewska, Gontran Verset, Qi Qi Wang, Caitlyn Stromko, Jaclyn Neely, Prianka Singh, Maria Jesus Jimenez Exposito, Masatoshi Kudo

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    1437 Analysis by treatment period and liver function in EMERALD-1: a phase 3 study of durvalumab ± bevacizumab + TACE in participants with embolization-eligible unresectable hepatocellular carcinoma

    1437 Analysis by treatment period and liver function in EMERALD-1: a phase 3 study of durvalumab ± bevacizumab + TACE in participants with embolization-eligible unresectable hepato... mā Stephen L. Chan, Masatoshi Kudo, Thomas Decaens, Joseph P. Erinjeri, Shukui Qin, Zhenggang Ren, Yasuaki Arai, Mohamed Bouattour, В. В. Бредер, Shi-Ming Lin, Jeong Heo, Jean‐Marie Péron, Vincenzo Mazzaferro, Quang T. Nguyen, Joong‐Won Park, Lünan Yan, Alejandro Molina Alavez, Chang-Fang Chiu, Kwong‐Ming Kee, Florinda Santos, Aibing Xu, Anil Veluvolu, Yoshitaka Inaba, Satheesh Chiradoni Thungappa, Farshid Dayyani, David Hsieh, Vaidehi Dave, Claire Morgan, Kerry Parsons, Mallory Makowsky, Riccardo Lencioni, Bruno Sangro

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: